Rifinah



Indications and Reactions:

Role Indications Reactions
Primary
Drug Use For Unknown Indication 26.4%
Tuberculosis 25.6%
Pulmonary Tuberculosis 16.5%
Product Used For Unknown Indication 5.0%
Antibiotic Prophylaxis 4.1%
Diabetes Mellitus 3.3%
Prophylaxis 3.3%
Adrenal Insufficiency 1.7%
Arthritis 1.7%
Contraception 1.7%
Cough 1.7%
Essential Hypertension 1.7%
Latent Tuberculosis 1.7%
Deep Vein Thrombosis 0.8%
Enteritis 0.8%
Exposure To Communicable Disease 0.8%
Hiv Infection 0.8%
Hypertension 0.8%
Lung Disorder 0.8%
Lymph Node Tuberculosis 0.8%
Vomiting 20.6%
Weight Decreased 8.8%
Psoriasis 5.9%
Rash Maculo-papular 5.9%
Sjogren's Syndrome 5.9%
Urticaria 5.9%
Visual Acuity Reduced 5.9%
Weight Increased 5.9%
C-reactive Protein Increased 2.9%
Drug Interaction 2.9%
Facial Palsy 2.9%
Hepatocellular Injury 2.9%
Hyperthyroidism 2.9%
Hypoglycaemia 2.9%
Jaundice Cholestatic 2.9%
Liver Function Test Abnormal 2.9%
Neutropenia 2.9%
No Adverse Event 2.9%
Pancreatitis Acute 2.9%
Panniculitis 2.9%
Secondary
Drug Use For Unknown Indication 20.8%
Tuberculosis 18.8%
Hiv Infection 9.6%
Ankylosing Spondylitis 7.1%
Product Used For Unknown Indication 6.6%
Rheumatoid Arthritis 6.1%
Prophylaxis 5.1%
Disseminated Tuberculosis 3.0%
Maternal Exposure Timing Unspecified 2.5%
Psoriasis 2.5%
Tuberculin Test Positive 2.5%
Unevaluable Event 2.5%
Cough 2.0%
Pain 2.0%
Renal Failure Chronic 2.0%
Diarrhoea 1.5%
Exposure To Communicable Disease 1.5%
Granuloma 1.5%
Arthralgia 1.0%
Arthritis 1.0%
Vomiting 14.9%
Rash Maculo-papular 12.8%
Jaundice 8.5%
Aplasia Pure Red Cell 6.4%
Leukocytoclastic Vasculitis 6.4%
Syncope 6.4%
Cytolytic Hepatitis 4.3%
Drug Eruption 4.3%
Foetal Exposure During Pregnancy 4.3%
Immune Reconstitution Syndrome 4.3%
Oedema Peripheral 4.3%
Paraesthesia 4.3%
Tuberculosis 4.3%
C-reactive Protein Increased 2.1%
Death 2.1%
Drug Exposure During Pregnancy 2.1%
Eye Infection Toxoplasmal 2.1%
Facial Palsy 2.1%
Gamma-glutamyltransferase Increased 2.1%
Hepatitis 2.1%
Concomitant
Rheumatoid Arthritis 15.9%
Product Used For Unknown Indication 13.4%
Drug Use For Unknown Indication 13.2%
Tuberculosis 12.5%
Hiv Infection 11.9%
Mycobacterial Infection 6.1%
Antibiotic Prophylaxis 3.8%
Type 2 Diabetes Mellitus 2.3%
Ankylosing Spondylitis 2.1%
Osteoporosis 2.1%
Antiviral Prophylaxis 1.9%
Depression 1.9%
Hypertension 1.9%
Pain 1.9%
Prophylaxis 1.9%
Bone Pain 1.7%
Pulmonary Tuberculosis 1.7%
Disseminated Tuberculosis 1.5%
Systemic Lupus Erythematosus 1.5%
Antifungal Prophylaxis 1.3%
Vomiting 9.9%
Cytomegalovirus Infection 8.5%
Immune Reconstitution Syndrome 8.5%
Death 5.6%
Hypothermia 5.6%
Lymphoproliferative Disorder 5.6%
Pancreatitis 5.6%
Pancreatitis Acute 5.6%
Ventricular Septal Defect 5.6%
Drug Reaction With Eosinophilia And Systemic Symptoms 4.2%
Interstitial Lung Disease 4.2%
Lymphadenitis 4.2%
Pulmonary Tuberculosis 4.2%
Pyrexia 4.2%
Stillbirth 4.2%
Paraesthesia 2.8%
Premature Baby 2.8%
Pruritus Generalised 2.8%
Pulmonary Embolism 2.8%
Renal Failure 2.8%
Interacting
Breast Cancer 15.0%
Type 2 Diabetes Mellitus 15.0%
Ankylosing Spondylitis 10.0%
Contraception 10.0%
Product Used For Unknown Indication 10.0%
Pulmonary Tuberculosis 10.0%
Thyroiditis 10.0%
Tuberculosis Skin Test Positive 10.0%
Antibiotic Prophylaxis 5.0%
Tuberculosis 5.0%
Hepatitis Acute 42.9%
Unintended Pregnancy 42.9%
Hypoglycaemia 14.3%